We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Praxair (PX) Hits New 52-Week High on Solid Q1 & '17 View
Read MoreHide Full Article
Shares of Praxair Inc. (PX - Free Report) reached a new 52-week high of $129.96 during its trading session on May 12. This apex improved upon the last 52-week high of $129.53 on May 5.
Post the release of first-quarter 2017 results on Apr 27, shares of the company yielded 3.38% return, as against 1.24% decline recorded by the Zacks categorized Chemicals Diversified industry.
On May 12, the company closed its trading session at $129.72, yielding year-to-date return of roughly 10.7%. The trading volume for the session was 1.1 million shares. Positive earnings estimate revisions for 2017 and 2018, along with an expected earnings growth rate of 12% for the next five years indicate the stock’s potential for further price appreciation.
Growth Drivers
Praxair’s financial performance was impressive in three of last four quarters, as evident from an average positive earnings surprise of 1.67%. In the first quarter, the company’s earnings of $1.37 per share surpassed the Zacks Consensus Estimate of $1.33 by 3.01%.
In 2017, Praxair anticipates benefiting from a talented workforce, sound product portfolio and new project wins. Base volume growth is predicted to be in sync with the prevailing macro conditions. Also, a solid backlog of $1.5 billion exiting the first quarter clearly reflects customers’ preference for the company’s world-class technology, high-quality products and gas supply services.
The company increased the lower-end of its previous guidance range of $5.45–$5.80 per share by 10 cents to $5.55–$5.80. Excluding 1% negative impact of foreign currency headwinds, earnings are predicted to grow 2–7% year over year. For the second quarter, the company expects earnings in the range of $1.38–$1.43 per share.
Estimate Revisions Show Potency
Over the last 30 days, the Zacks Consensus Estimate for Praxair increased 0.2% to $5.73 for 2017 and 0.2% to $6.26 for 2018. Also, these estimates represent year-over-year growth of 4.5% for 2017 and 9.4% for 2018.
Huntsman Corporation’s earnings estimates for 2017 and 2018 were revised upward over the last 60 days. Also, its average earnings surprise for the last four quarters was a positive 20.12%.
Kronos Worldwide’s financial performance in three out of last four quarters was impressive, with an average positive earnings surprise of 64.14%. Also, its earnings estimates for 2017 improved over the last 60 days.
BASF SE’s average earnings surprise for the last four quarters was a positive 3.02%. Also, its earnings estimates for 2017 and 2018 improved in the last 60 days.
5 Trades Could Profit "Big-League" from Trump Policies
If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.
Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Praxair (PX) Hits New 52-Week High on Solid Q1 & '17 View
Shares of Praxair Inc. (PX - Free Report) reached a new 52-week high of $129.96 during its trading session on May 12. This apex improved upon the last 52-week high of $129.53 on May 5.
Post the release of first-quarter 2017 results on Apr 27, shares of the company yielded 3.38% return, as against 1.24% decline recorded by the Zacks categorized Chemicals Diversified industry.
On May 12, the company closed its trading session at $129.72, yielding year-to-date return of roughly 10.7%. The trading volume for the session was 1.1 million shares. Positive earnings estimate revisions for 2017 and 2018, along with an expected earnings growth rate of 12% for the next five years indicate the stock’s potential for further price appreciation.
Growth Drivers
Praxair’s financial performance was impressive in three of last four quarters, as evident from an average positive earnings surprise of 1.67%. In the first quarter, the company’s earnings of $1.37 per share surpassed the Zacks Consensus Estimate of $1.33 by 3.01%.
In 2017, Praxair anticipates benefiting from a talented workforce, sound product portfolio and new project wins. Base volume growth is predicted to be in sync with the prevailing macro conditions. Also, a solid backlog of $1.5 billion exiting the first quarter clearly reflects customers’ preference for the company’s world-class technology, high-quality products and gas supply services.
The company increased the lower-end of its previous guidance range of $5.45–$5.80 per share by 10 cents to $5.55–$5.80. Excluding 1% negative impact of foreign currency headwinds, earnings are predicted to grow 2–7% year over year. For the second quarter, the company expects earnings in the range of $1.38–$1.43 per share.
Estimate Revisions Show Potency
Over the last 30 days, the Zacks Consensus Estimate for Praxair increased 0.2% to $5.73 for 2017 and 0.2% to $6.26 for 2018. Also, these estimates represent year-over-year growth of 4.5% for 2017 and 9.4% for 2018.
Praxair, Inc. Price and Consensus
Praxair, Inc. Price and Consensus | Praxair, Inc. Quote
With a market capitalization of $37 billion, Praxair currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the chemicals industry include Huntsman Corporation (HUN - Free Report) , Kronos Worldwide Inc (KRO - Free Report) and BASF SE (BASFY - Free Report) , each boasting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Huntsman Corporation’s earnings estimates for 2017 and 2018 were revised upward over the last 60 days. Also, its average earnings surprise for the last four quarters was a positive 20.12%.
Kronos Worldwide’s financial performance in three out of last four quarters was impressive, with an average positive earnings surprise of 64.14%. Also, its earnings estimates for 2017 improved over the last 60 days.
BASF SE’s average earnings surprise for the last four quarters was a positive 3.02%. Also, its earnings estimates for 2017 and 2018 improved in the last 60 days.
5 Trades Could Profit "Big-League" from Trump Policies
If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.
Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>